Often, the action in a stock is based on investors perceptions, but it can be a circular event. Not only is the price action representative of perception, but it can influence perception too. In the case of Ishares Nasdaq Biotechnology E (NYSE: IBB) we can see this in the charts. The data for IBB in the summary table and trading plans below are intended to provide an example of how to extrapolate this. Our data was current at the time of publication, but it is not updated in real time here. If you want real time updates, or data on a different stock, please get one here Unlimited Real Time Reports .
Technical Summary
Term ? | Near | Mid | Long |
---|---|---|---|
Bias | Strong | Weak | Strong |
P1 | 0 | 0 | 151.05 |
P2 | 156.32 | 152.21 | 161.89 |
P3 | 158.88 | 159.41 | 172.33 |
Long Term Trading Plans for IBB
March 17, 2021, 9:30 pm ET
The Technical Summary and Trading Plans for IBB help you determine where to buy, sell, and set risk controls. The data is best used in conjunction with our Market Analysis and Stock Correlation Filters too, because those help us go with the flow of the market as well. Going with the flow is extremely important, so review our Market Analysis with this IBB Report.
IBB - (Long) Support Plan
The technical summary data tells us to buy IBB near 151.05 with an upside target of 161.89. This data also tells us to set a stop loss @ 150.61 to protect against excessive loss in case the stock begins to move against the trade. 151.05 is the first level of support below 158.19 , and by rule, any test of support is a buy signal. In this case, support 151.05 would be being tested, so a buy signal would exist.
IBB - (Short) Resistance Plan
The technical summary data is suggesting a short of IBB as it gets near 161.89 with a downside target of 151.05. We should have a stop loss in place at 162.36though. 161.89 is the first level of resistance above 158.19, and by rule, any test of resistance is a short signal. In this case, if resistance 161.89 is being tested, so a short signal would exist.